CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
33.51 -0.27(-0.80%) NAV as on 22 May 2026
7.99 % 1 M
12.15 % 1 Y
25.53 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.96

As on 30 Apr, 2026
age-icon Age :

6 yrs 10 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

900.87 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.62

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Apr 30 ,2026
Others 1.39 %
Equity 98.61 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.17 %
Apollo Hospitals Enterprise Ltd.7.20 %
Torrent Pharmaceuticals Ltd.4.76 %
JB Chemicals & Pharmaceuticals...4.71 %
Aurobindo Pharma Ltd.4.49 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs77.31
Hospital & Healthcare Services19.60
Business Support1.00
Chemicals0.69
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)18.2216.3626.4529.3930.19
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.33 428.44 699.55 814.95 858.87
Scheme Returns(%)(Absolute)12.40-10.2661.3810.034.21
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity33.51-0.27(-0.80%)NAV As on 22 May, 202610-Jul-2019Inception Date900.87AUM In Cr.12.15%1Y25.53%3Y12.99%5Y19.24%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.79-0.28(-0.67%)NAV As on 22 May, 202613-Jul-2018Inception Date6,668.95AUM In Cr.9.54%1Y28.96%3Y16.08%5Y19.95%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.30-0.67(-1.55%)NAV As on 22 May, 202602-Jul-2018Inception Date2,939.23AUM In Cr.14.89%1Y26.93%3Y14.69%5Y20.05%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity466.26-4.38(-0.93%)NAV As on 22 May, 202614-Jul-1999Inception Date4,323.29AUM In Cr.11.27%1Y26.71%3Y15.78%5Y16.08%Since Inception
LIC MF Healthcare Fund-Reg(G)Very HighEquity31.08-0.38(-1.21%)NAV As on 22 May, 202628-Feb-2019Inception Date84.53AUM In Cr.10.77%1Y24.62%3Y11.08%5Y16.97%Since Inception